We are live on ! Find out more
XBIT icon

XBiotech
XBIT

31 hedge funds and large institutions have $8.18M invested in XBiotech in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.79% less ownership

Funds ownership: 8.93% → 5.14% (-3.8%)

28% less funds holding

Funds holding: 43 → 31 (-12)

51% less call options, than puts

Call options by funds: $154K | Put options by funds: $316K

52% less capital invested

Capital invested by funds: $16.9M → $8.18M (-$8.76M)

71% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 17

81% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 16

Holders
31
Holders Change
-12
Holders Change %
-27.91%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
16
Closed
17
Calls
$154K
Puts
$316K
Net Calls
-$162K
Net Calls Change
-$44K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$939K
2
PP
Paloma Partners
Connecticut
+$333K
3
ECM
Element Capital Management
New York
+$332K
4
LP
LMR Partners
United Kingdom
+$155K
5
BCM
BlueCrest Capital Management
Jersey
+$83.3K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.71M
2
State Street
State Street
Massachusetts
-$1.32M
3
Northern Trust
Northern Trust
Illinois
-$767K
4
TCIM
TIAA CREF Investment Management
New York
-$244K
5
AllianceBernstein
AllianceBernstein
Tennessee
-$228K

XBIT Hedge Fund Activity: Q2 2018 in Review

31 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2018, worth a combined $8.18M — down 52% from $16.9M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of XBIT and 5 opened new positions — a net loss of 12 holders — while 16 trimmed existing stakes and 3 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $939K. The largest seller was BlackRock, cutting an estimated $3.71M.

  • 31 institutional investors held XBiotech (XBIT) as of Q2 2018, down from 43 in Q1 2018.
  • Funds reported $8.18M of XBiotech stock for Q2 2018, down 52% quarter-over-quarter.
  • 5 funds opened new XBiotech positions in Q2 2018 and 17 closed out, a net change of -12 holders.
  • The largest XBiotech buyer in Q2 2018 was Millennium Management, an estimated $939K added.
  • The largest XBiotech seller in Q2 2018 was BlackRock, an estimated $3.71M sold.

Based on aggregated 13F filings for Q2 2018.